Argen X SE Overview
Latest P/E ratio for Argen X SE: 35.9 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow35.90
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for ARGX is 35.9. That is above the Healthcare sector average of 25.75. Investors often review this figure alongside Argen X SE's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ARGX currently prints 35.9 for P/E ratio, while the sector average sits near 25.75. That is roughly 39.4% above the sector mean. Large gaps often invite a closer look at Argen X SE's growth, margins, and balance sheet.
A P/E ratio of 35.9 for Argen X SE is not 'good' or 'bad' on its own. Compare it with the peer average (25.75) and with ARGX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ARGX's P/E ratio (35.9), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Argen X SE's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
